Search results
Results from the WOW.Com Content Network
The Self-administered Gerocognitive Examination is a brief cognitive assessment instrument for mild cognitive impairment (MCI) and early dementia, created by Douglas Scharre, Professor of Clinical Neurology and Psychiatry at Ohio State University Wexner Medical Center in Columbus, Ohio.
Other tests are also used, such as the Hodkinson [12] abbreviated mental test score (1972), Geriatric Mental State Examination (GMS), [13] or the General Practitioner Assessment of Cognition, bedside tests such as the 4AT (which also assesses for delirium), and computerised tests such as CoPs [14] and Mental Attributes Profiling System, [15] as ...
The MoCA is a one-page 30-point test administered in approximately 10 minutes. [2] The test and administration instructions are available for clinicians online. The test is available in 46 languages and dialects (as of 2017). In this clock drawing task, the subject is asked to draw a clock with the hours and showing the time 2:30.
New research finds a blood test accurately diagnoses Alzheimer’s disease in patients. The blood test was 90% accurate in the study. This blood test is currently available in the U.S.
A new test may help predict who is at risk for Alzheimer's disease. ABC explains, "It measures a patient's risk of mental impairment based on several factors, including how quickly the patient can ...
Also in July, a work group convened by the National Institute on Aging and the Alzheimer’s Association proposed a new definition of Alzheimer’s disease to be used in clinical practice ...
With increasing clinical focus on dementia, there is likewise increasing interest in pharmacology in the development of drugs to halt, or slow the progression of dementia-related illness such as Alzheimer's Disease. Therefore, early and accurate diagnosis of dementia and staging can be essential to proper clinical care.
And for the remaining 515 participants originally seen by a primary care doctor, the test was again about 90% accurate in diagnosing Alzheimer’s disease, compared to primary care physicians ...